Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07147179 · ClinicalTrials.gov registry record · NA
Short Course Radiotherapy
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT07147179 is a NA study that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 15 participants.
The verdict
NCT07147179, a NA study, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a single arm prospective pilot trial determining the safety of short-course radiation therapy in pediatric patients with incurable central nervous system malignancies.
Interventions
- RADIATION Short Course Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-04-02 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07147179
The ClinicalTrials.gov registry entry for NCT07147179 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Short Course Radiotherapy is the first listed.
NCT07147179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07147179 about?
NCT07147179 is a clinical study titled "Short Course Radiotherapy". This is a single arm prospective pilot trial determining the safety of short-course radiation therapy in pediatric patients with incurable central nervous system malignancies.
What is the current status of trial NCT07147179?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-04-02. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07147179?
The interventions under investigation include: Short Course Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT07147179?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.